SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022­ and 2023

Lustig, Yaniv; Canetti, Michal; Indenbaum, Victoria; Peretz, Yovel; Weiss-Ottolenghi, Yael; Margalit, Ili; Asraf, Keren; Levin, Tal; Zuckerman, Neta; Tomer, Enosh; Mandelboim, Michal; Doolman, Ram; Barda, Noam; Regev-Yochay, Gili

doi:10.3201/eid3005.231739

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023

5-2024
By Lustig, Yaniv ; Canetti, Michal ; Indenbaum, Victoria ; ...
http://dx.doi.org/10.3201/eid3005.231739
Source: Emerg Infect Dis. 2024; 30(5):1050-1052

[PDF-702.80 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Lustig, Yaniv ; Canetti, Michal ; Indenbaum, Victoria ; Peretz, Yovel ; Weiss-Ottolenghi, Yael ; ... More +

Lustig, Yaniv ; Canetti, Michal ; Indenbaum, Victoria ; Peretz, Yovel ; Weiss-Ottolenghi, Yael ; Margalit, Ili ; Asraf, Keren ; Levin, Tal ; Zuckerman, Neta ; Tomer, Enosh ; Mandelboim, Michal ; Doolman, Ram ; Barda, Noam ; Regev-Yochay, Gili Less -
Description:

Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain-specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.
Subjects:

[+]

Adult Aged Antibodies, Neutralizing Antibodies, Viral COVID-19 COVID-19 Vaccines Female Humans Immunoglobulin G Male Middle Aged Neutralization Tests SARS-CoV-2 Spike Glycoprotein, Coronavirus
Keywords:

[+]

Antibodies IgG Israel Neutralizing Antibodies Respiratory Infections Vaccine-preventable Diseases Vaccines Viruses XBB Variant
Source:

Emerg Infect Dis. 2024; 30(5):1050-1052
Pubmed ID:

38666742
Pubmed Central ID:

PMC11060444
Document Type:

Journal Article
Genre:

Research Letter
Place as Subject:

Israel
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:3e7669a733100a32acdcc90a4e764aeea36e3fbb42edaa6a9785b6e2280271bd
Download URL:

https://stacks.cdc.gov/view/cdc/154881/cdc_154881_DS1.pdf
File Type:

	23-1739-F.gif	gif
	23-1739-F.jpg	jpeg
	23-1739-Techapp-s1.pdf	pdf
	23-1739.nxml	xml

More +

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022­ and 2023

Details:

Supporting Files

You May Also Like

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023